CVS to Buy Omnicare in $12.7 Billion Pharmacy Expansion Deal

CVS Health Corp., the biggest U.S. retailer of prescription drugs, agreed to acquire nursing-home pharmacy Omnicare Inc. for a total enterprise value of $12.7 billion.

CVS will pay $98 per share in cash, the companies said in a statement on Thursday. Omnicare, with a market value of about $9.2 billion, hired advisers to explore a sale earlier this year. The deal includes about $2.3 billion in debt.

Omnicare delivers drugs and helps senior-living facilities manage residents’ medications. CVS is the nation’s second-largest pharmacy benefits manager, handling drug plans for health insurers and employers. In its most recent quarter, growth in sales from that business far outpaced the company’s retail division.

“CVS Health will significantly expand its ability to dispense prescriptions in assisted living and long term care facilities, serving the senior patient population” with the transaction, it said.

Cvs

 Both companies are big in Medicare Part D, a federal program that subsidizes medicine for retirees, Charles Rhyee, a New York-based analyst for Cowen Group Inc., said in an interview last month. Omnicare also drew interest from industry leader Express Scripts Holding Co., people with knowledge of the matter said last month.

Board Approvals

The boards of both CVS and Omnicare approved the transaction, which holders of Omnicare’s common stock must also clear, according to the statement. It’s expected to close, pending regulatory approval, at the end of the year and boost CVS’s adjusted earnings per share by 20 cents next year, CVS said.

Demand for pharmacy services is rising as patients, insurers and companies look for ways to manage costs with drug prices increasing. Pharmacy-services providers are combining to gain a bigger piece of the growing market.

UnitedHealth Group Inc. said in March that it would buy Catamaran Corp. in a $12.8 billion deal to create a third-place competitor. That deal came on the heels of Rite Aid Corp.’s agreement to buy pharmacy benefits manager EnvisionRx for about $2 billion.

Express Scripts became the biggest pharmacy-benefits management company after purchasing Medco Health Solutions Inc. three years ago for $34 billion including net debt.

Barclays Plc and Evercore Partners Inc. acted as financial advisers and investment bankers to CVS. Sullivan & Cromwell LLP advised the company on legal matters and Dechert LLP on antitrust questions.

Bank of America Merrill Lynch and Centerview Partners were financial advisors to Omnicare, and White & Case LLP its legal counsel.

Related Posts:
Iran’s expansion of uranium enrichment ‘a big step in the wrong direction’
Speaking About News

Iran’s expansion of uranium enrichment activities in defiance of key nuclear commitments is “a big step in the wrong direction,” Read more

State Legislature’s Should Restrict Access to Medicinal Marijuana During Pregnancy
Speaking About News

Ryan Neuhaus, As medicinal marijuana is becoming more popular across the United States, state legislators should note that using drugs Read more

Giuliani associate now willing to comply with Trump impeachment inquiry – lawyer
Speaking About News

Aram Roston, Lev Parnas, an indicted Ukrainian-American businessman who has ties to President Donald Trump’s personal lawyer, Rudy Giuliani, is Read more

The New T-Mobile/Sprint: Leadership Strategies
Speaking About News

Jason Wingard, The Federal Communications Commission voted to approve a merger between T-Mobile and Sprint, two of the largest cellular Read more

Tags: